Atrovent HFA and Bethanechol Oral, Subcutaneous
Determining the interaction of Atrovent HFA and Bethanechol Oral, Subcutaneous and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using bethanechol together with ipratropium may reduce the effectiveness of one or both medications. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Anticholinergic agents and other agents with significant anticholinergic activity (e.g., clozapine, class IA antiarrhythmics especially disopyramide) may antagonize the effects of direct-acting cholinergic agents such as bethanechol, carbachol, cevimeline, and pilocarpine. This interaction is sometimes desirable and is the basis for using atropine in the treatment of excessive muscarinic side effects and cholinergic crisis induced by cholinergic overdose. Conversely, cholinergic agents may also counteract the pharmacologic effects of anticholinergic agents and other agents that rely partially on their anticholinergic activity for therapeutic effects (e.g., some antiparkinsonian and antiemetic/antivertigo agents). The mechanism of interaction involves opposing pharmacodynamic action on muscarinic receptor sites.
MANAGEMENT: It may be appropriate to avoid concomitant use of anticholinergic agents and cholinergic agents, depending on the needs of the patient. If concurrent use is necessary, the patient should be monitored for reduced pharmacologic effects of both drugs.
- "Product Information. Salagen Tablets (pilocarpine)." Boehringer-Ingelheim, Ridgefield, CT.
- Benjamin KW "Toxicity of ocular medications." Int Ophthalmol Clin 19 (1979): 199-255
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: n.a.
Generic Name: bethanechol
Brand name: Duvoid, Urecholine
Synonyms: Bethanechol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atrovent HFA-Bethkis
- Atrovent HFA-Bethkis inhalation
- Atrovent HFA-Bethkis Inhalation Solution
- Atrovent HFA-Betimol
- Atrovent HFA-Betnovate
- Atrovent HFA-Betnovate-1/2
- Bethanechol Oral, Subcutaneous-Atrovent Inhalation, oral/nebulization
- Bethanechol Oral, Subcutaneous-Atrovent Nasal
- Bethanechol Oral, Subcutaneous-Atrovent Nasal Spray
- Bethanechol Oral, Subcutaneous-Atrovent Nasal Spray eent
- Bethanechol Oral, Subcutaneous-ATryn
- Bethanechol Oral, Subcutaneous-Attapulgite Liquid and Suspension